Literature DB >> 30128518

Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms.

Malin Hultcrantz1, Magnus Björkholm1, Ola Landgren2, Sigurdur Y Kristinsson3, Therese M L Andersson4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30128518     DOI： 10.7326/L18-0245

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  2 in total

1.  Circulating Protein Disulfide Isomerase Is Associated with Increased Risk of Thrombosis in JAK2-Mutated Myeloproliferative Neoplasms.

Authors:  Anish V Sharda; Thomas Bogue; Alexandra Barr; Lourdes M Mendez; Robert Flaumenhaft; Jeffrey I Zwicker
Journal:  Clin Cancer Res       Date:  2021-08-16       Impact factor: 13.801

2.  Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients.

Authors:  Joan How; Charlotte Story; Siyang Ren; Donna Neuberg; Rachel P Rosovsky; Gabriela S Hobbs; Jean M Connors
Journal:  Blood Cancer J       Date:  2021-11-05       Impact factor: 11.037
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.